While ApoA1 (P = 0.002, OR 0.223, 95 % CI 0.086–0.574) reduced AD risk, and HCY (P = 0.002, OR 1.065, 95 % CI 1.024–1.109) increased AD risk (Table 3). Here, APOA1 is linked to Alzheimer disease.